-
Symbol
-
KPTI on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
6.55M shares
-
Security Ownership
-
5.18%
Adage Capital Management, L.P. ownership in Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI)
2025-02-12 - Adage Capital Management, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.55M shares of Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI).
This represents 5.18% percent ownership of the company.